We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.
For more information visit our privacy policy.ContractSitagliptin Catalyst Supply Agreement • May 5th, 2020 • New York
Contract Type FiledMay 5th, 2020 JurisdictionEX-10.25 3 exhibit1025sitagliptinsupp.htm EXHIBIT [***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. Exhibit 10.25 EXECUTION VERSION SITAGLIPTIN CATALYST SUPPLY AGREEMENT By and Between MERCK SHARP AND DOHME CORP And CODEXIS, INC. SITAGLIPTIN CATALYST SUPPLY AGREEMENT This Sitagliptin Catalyst Supply Agreement (this “AGREEMENT”) is made and entered into as of February 1, 2012 (“EFFECTIVE DATE”), by and between MERCK SHARP AND DOHME CORP ("MERCK") (formerly known as Merck & Co. Inc.), a New Jersey corporation having a place of business at One Merck Drive, Whitehouse Station, New Jersey 08889-0100 (“MERCK”), and CODEXIS, INC., a Delaware corporation having a place of business at 200 Penobscot Drive, Redwood City, CA 94063 (“CODEXIS”). WITNESSETH: WHEREAS, CODEXIS owns or possesses an exclusive license to the CODEXIS PATENTS and CODEXIS
SITAGLIPTIN CATALYST SUPPLY AGREEMENT By and Between MERCK SHARP AND DOHME CORP And CODEXIS, INC.Sitagliptin Catalyst Supply Agreement • April 2nd, 2013 • Codexis Inc • Industrial organic chemicals • New York
Contract Type FiledApril 2nd, 2013 Company Industry JurisdictionThis Sitagliptin Catalyst Supply Agreement (this “AGREEMENT”) is made and entered into as of February 1, 2012 (“EFFECTIVE DATE”), by and between MERCK SHARP AND DOHME CORP ("MERCK") (formerly known as Merck & Co. Inc.), a New Jersey corporation having a place of business at One Merck Drive, Whitehouse Station, New Jersey 08889-0100 (“MERCK”), and CODEXIS, INC., a Delaware corporation having a place of business at 200 Penobscot Drive, Redwood City, CA 94063 (“CODEXIS”).